As of July 14, 2026, Prime Medicine, Inc. (PRME) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. Prime Medicine, Inc. has a market capitalization of $641.19M, 180.62M shares outstanding, 194 institutional holders tracked. Key dilution vectors include approximately 4 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
24%
💰 Capital Raise
35%
• Low cash runway: 4 months remaining
🔄 Reverse Split
15%
• Only 4 months cash — financial pressure
📉 Score Deterioration
10%
• Score in HIGH risk zone (61/100)
💹 Market Data
Market Cap$641.19M
Shares Outstanding180.62M
Float108.73M
Cash$64.11M
Debt$114.51M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 7.4% shares (2026Q1 vs prior)
194 institutional holders · 112.26M shares
#1
Alphabet Inc.
16.56M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
8.95M shares
#3
BlackRock, Inc.
8.50M shares
📉 Short Interest
Short Interest34.73M
Days to Cover9.1
% of Float31.9%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2022
EFFECT
EFFECT
Mar 04, 2026
4
INSIDER TRANSACTION
Feb 27, 2026
4
INSIDER TRANSACTION
Feb 24, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for PRME Shareholders
Prime Medicine, Inc. (PRME) has a DilutionScore of 61/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.
Cash runway is a key watch item: PRME has approximately 4 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.
DilutionWatch tracks over 25 SEC filing types for PRME in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PRME alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track PRME Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PRME — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for PRME
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.